MAPT and early-onset autosomal dominant Alzheimer disease: In a recent study, gold nanoparticles were conjugated with β-Boswellic acid and those hybrid nanoparticles were found to inhibit tau protein aggregation and prevented the formation of tau fibrils, and therefore may be applicable in the potential treatment of Alzheimer’s disease [24].